Log in to save to my catalogue

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results f...

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results f...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dcb4dd0b74754b69b1bb5b811f6e5fda

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Publication information

Publisher

England: EULAR

More information

Scope and Contents

Contents

ObjectiveWe investigated prolonged COVID-19 symptom duration, defined as lasting 28 days or longer, among people with systemic autoimmune rheumatic diseases (SARDs).MethodsWe analysed data from the COVID-19 Global Rheumatology Alliance Vaccine Survey (2 April 2021–15 October 2021) to identify people with SARDs reporting test-confirmed COVID-19. Par...

Alternative Titles

Full title

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dcb4dd0b74754b69b1bb5b811f6e5fda

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dcb4dd0b74754b69b1bb5b811f6e5fda

Other Identifiers

ISSN

2056-5933

E-ISSN

2056-5933

DOI

10.1136/rmdopen-2022-002587

How to access this item